Literature DB >> 17983930

Post-transplantation osteoporosis.

Emily Stein1, Peter Ebeling, Elizabeth Shane.   

Abstract

Osteoporosis is prevalent in transplant recipients and is related to pre- and post-transplantation factors. Low bone density and fractures may antedate transplantation, related to traditional risk factors for osteoporosis, effects of chronic illness, and end-stage organ failure and its therapy, on the skeleton. Bone loss after transplantation is related to adverse effects of immunosuppressive drugs (glucocorticoids and calcineurin inhibitors) on bone remodeling. Newer immunosuppressive medications may permit lower doses of glucocorticoids and may be associated with decreased bone loss and fractures. Bisphosphonates are currently the most effective agents for the prevention and treatment of post-transplantation osteoporosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17983930     DOI： 10.1016/j.ecl.2007.07.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  20 in total

Review 1.  Osteoporosis after transplantation.

Authors:  Carolina A Moreira Kulak; Victoria Z Cochenski Borba; Jaime Kulak; Melani Ribeiro Custódio
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

Review 2.  Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner.

Authors:  Daniel Benten; Katharina Staufer; Martina Sterneck
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

Review 3.  Outcomes following cardiac transplantation in adults.

Authors:  Sai Bhagra; Jayan Parameshwar
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-02-15

4.  Factors associated with 1,25-dihydroxyvitamin D3 concentrations in liver transplant recipients: a prospective observational longitudinal study.

Authors:  Agnieszka Prytuła; Johan Vande Walle; Hans Van Vlierberghe; Jean-Marc Kaufman; Tom Fiers; Jo Dehoorne; Ann Raes
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

5.  Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.

Authors:  Elizabeth Shane; Adi Cohen; Emily M Stein; Donald J McMahon; Chiyuan Zhang; Polly Young; Kavita Pandit; Ronald B Staron; Elizabeth C Verna; Robert Brown; Susan Restaino; Donna Mancini
Journal:  J Clin Endocrinol Metab       Date:  2012-09-28       Impact factor: 5.958

6.  Low bone density and fractures before and after pediatric lung transplantation.

Authors:  Melissa S Putman; Tregony Simoneau; Henry A Feldman; Alexandra Haagensen; Debra Boyer
Journal:  Bone       Date:  2018-03-27       Impact factor: 4.398

7.  Impaired Bone Mineral Density in Pediatric Patients with Chronic Graft-versus-Host Disease.

Authors:  Nataliya P Buxbaum; Cemre Robinson; Ninet Sinaii; Alexander Ling; Lauren M Curtis; Steven Z Pavletic; Kristin Baird; Maya B Lodish
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-01       Impact factor: 5.742

8.  Incidental vertebral compression fractures in imaging studies: Lessons not learned by radiologists.

Authors:  Tommaso Bartalena; Maria Francesca Rinaldi; Cecilia Modolon; Lucia Braccaioli; Nicola Sverzellati; Giuseppe Rossi; Eugenio Rimondi; Maurizio Busacca; Ugo Albisinni; Donald Resnick
Journal:  World J Radiol       Date:  2010-10-28

9.  Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients.

Authors:  Mohammad Bilal Siddiqui; Samarth Patel; Chandra Bhati; Trevor Reichman; Kenyada Williams; Carolyn Driscoll; Erika Liptrap; Mary E Rinella; Richard K Sterling; M Shadab Siddiqui
Journal:  Transplant Proc       Date:  2019 Jul - Aug       Impact factor: 1.066

Review 10.  Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.

Authors:  Srinivasan Dasarathy
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.